The efficacy and safety of live attenuated vaccine in patients treated with steroid and immunosuppresive drugs: A prospective study
Not Applicable
- Conditions
- collagen diseases, kidney diseases, digestive diaseases, liver diaseases, neurological diseases, kidney transplant patients
- Registration Number
- JPRN-UMIN000018627
- Lead Sponsor
- Department of Pediatrics, Yokohama City University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
1. Steroid use of more than 1mg/kg/d. 2. For renal transplant recipients, <1 year since transplantation or acute rejection within the previous 6 months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) Assessment of antibody acquisition after vaccination classified by each virus. 2) Analysis of long maintenance of acquired immunity. 3) Analysis of incididence of adverse events.
- Secondary Outcome Measures
Name Time Method 1) Analysis of causes of vaccine failure. 2) Analysis of causes of adverse events. 3) Analysis of effect for prevention of virus infection.